Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Wu

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|August 6, 1988
Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infectionA S Lok, C L Lai, P C Wu, et al.
Journal of Medical Virology|May 1, 1986
Response to hepatitis B vaccine in family members of HBsAg carriersA S Lok, C L Lai, P C Wu, et al.
Journal of Gastroenterology and Hepatology|July 1, 1989
Comparison of two plasma-derived hepatitis B vaccines: long-term report of a prospective, randomized trialJ Y Lau, C L Lai, P C Wu, et al.
Gene|June 15, 1992
Histidine ammonia-lyase from Streptomyces griseusP C Wu, T A Kroening, P J White, et al.
Journal of Medical Microbiology|December 18, 1998
The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosaY H Samaranayake, P C Wu, L P Samaranayake, et al.
American Journal of Obstetrics and Gynecology|January 1, 1982
Roentgenologic manifestations of pulmonary metastases in choriocarcinoma and invasive moleH C Sung, P C Wu, M H Hu, et al.
European Journal of Neurology|December 18, 2019
Do different treatment strategies of galcanezumab have a similar effect on migraine?I-H Huang, P-C Wu, Y-H Lee, et al.
The British Journal of Dermatology|July 1, 1979
Tuberculoid cutaneous infection due to a niacin-positive Mycobacterium cheloneiS Y Yip, P C Wu, W C Chan, et al.
The Journal of Bone and Joint Surgery. American Volume|February 1, 1989
Osteomalacia secondary to osteosarcoma. A case reportC L Cheng, J Ma, P C Wu, et al.
Journal of Pharmaceutical Sciences|September 6, 2001
Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancerP C Wu, Y Obata, M Fujikawa, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|August 6, 1988
Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infectionA S Lok, C L Lai, P C Wu, et al.
Journal of Medical Virology|May 1, 1986
Response to hepatitis B vaccine in family members of HBsAg carriersA S Lok, C L Lai, P C Wu, et al.
Journal of Gastroenterology and Hepatology|July 1, 1989
Comparison of two plasma-derived hepatitis B vaccines: long-term report of a prospective, randomized trialJ Y Lau, C L Lai, P C Wu, et al.
Gene|June 15, 1992
Histidine ammonia-lyase from Streptomyces griseusP C Wu, T A Kroening, P J White, et al.
Journal of Medical Microbiology|December 18, 1998
The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosaY H Samaranayake, P C Wu, L P Samaranayake, et al.
American Journal of Obstetrics and Gynecology|January 1, 1982
Roentgenologic manifestations of pulmonary metastases in choriocarcinoma and invasive moleH C Sung, P C Wu, M H Hu, et al.
European Journal of Neurology|December 18, 2019
Do different treatment strategies of galcanezumab have a similar effect on migraine?I-H Huang, P-C Wu, Y-H Lee, et al.
The British Journal of Dermatology|July 1, 1979
Tuberculoid cutaneous infection due to a niacin-positive Mycobacterium cheloneiS Y Yip, P C Wu, W C Chan, et al.
The Journal of Bone and Joint Surgery. American Volume|February 1, 1989
Osteomalacia secondary to osteosarcoma. A case reportC L Cheng, J Ma, P C Wu, et al.
Journal of Pharmaceutical Sciences|September 6, 2001
Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancerP C Wu, Y Obata, M Fujikawa, et al.
Pageof 21